Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-02-15
1995-01-03
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548184, C07D41712, A61K 31425
Patent
active
053787196
ABSTRACT:
Novel imidazoles of formula I ##STR1## wherein R.sub.1 and R.sub.4 are lower alkyl, lower alk-2-en-1-yl or lower alk-2-yn-1-yl,
REFERENCES:
patent: 3699116 (1972-10-01), Meisel
patent: 4697020 (1987-09-01), Storni et al.
patent: 5137897 (1992-08-01), Thorwart
March, Advanced Org. Chem. 3rd Ed. pp. 784-786 (1985).
Weisenberg, et al. "Suppression and augmentation of rat adjuvant arthritis with monoclonal anti-interferon-gamma antibody" Clin. Exp. Immunol. 78:245.
Vigorita, et al. "[3,3'-Bi-1,3-thiazolidine]-4,4'-dione system," Chemical Abstracts 102(11):18 No. 89678x (1985).
European Patent Office Search Mar. 12, 1993.
Ciba-Geigy Corporation
Fishman Irving M.
Gerstl Robert
Kaiser Karen G.
LandOfFree
Imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2211787